FDA recall record

Central Admixture Pharmacy Services fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% recall — FDA D-0016-2024

Lack of assurance of sterility:

Class IIclassification
D-0016-2024official record ID
Oct 11, 2023report date

Recall record at a glance

Official recordD-0016-2024
CategoryDrug Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmCentral Admixture Pharmacy Services Inc.
Report dateOct 11, 2023
Recall initiation dateSep 21, 2023
Quantity60 250 mL bags
LocationSan Diego, CA, United States

Official product description

fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total Volume = 250 mL, Total fentaNYL 500 mcg/250 mL, 250 mL bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2081-1

Why the product was recalled

Lack of assurance of sterility:

Distribution information

Nationwide in the USA

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.